Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery

Jae-Hyung Jang, J. T. Koerber, K. Gujraty, S. R. Bethi, R. S. Kane, D. V. Schaffer

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Adeno-associated viral (AAV) vectors, which are undergoing broad exploration in clinical trials, have significant promise for therapeutic gene delivery because of their safety and delivery efficiency. Gene delivery technologies capable of mediating localized gene expression may further enhance the potential of AAV in a variety of therapeutic applications by reducing spread outside a target region, which may thereby reduce off-target side effects. We have genetically engineered an AAV variant capable of binding to surfaces with high affinity through a hexa-histidine metal-binding interaction. This immobilized AAV vector system mediates high-efficiency delivery to cells that contact the surface and thus may have promise for localized gene delivery, which may aid numerous applications of AAV delivery to gene therapy.

Original languageEnglish
Pages (from-to)1384-1389
Number of pages6
JournalGene Therapy
Volume17
Issue number11
DOIs
Publication statusPublished - 2010 Nov 1

Fingerprint

Histidine
Immobilization
Genes
Genetic Therapy
Metals
Clinical Trials
Technology
Safety
Gene Expression
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Jang, Jae-Hyung ; Koerber, J. T. ; Gujraty, K. ; Bethi, S. R. ; Kane, R. S. ; Schaffer, D. V. / Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery. In: Gene Therapy. 2010 ; Vol. 17, No. 11. pp. 1384-1389.
@article{d1c0efe85030459889d4291598abcda4,
title = "Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery",
abstract = "Adeno-associated viral (AAV) vectors, which are undergoing broad exploration in clinical trials, have significant promise for therapeutic gene delivery because of their safety and delivery efficiency. Gene delivery technologies capable of mediating localized gene expression may further enhance the potential of AAV in a variety of therapeutic applications by reducing spread outside a target region, which may thereby reduce off-target side effects. We have genetically engineered an AAV variant capable of binding to surfaces with high affinity through a hexa-histidine metal-binding interaction. This immobilized AAV vector system mediates high-efficiency delivery to cells that contact the surface and thus may have promise for localized gene delivery, which may aid numerous applications of AAV delivery to gene therapy.",
author = "Jae-Hyung Jang and Koerber, {J. T.} and K. Gujraty and Bethi, {S. R.} and Kane, {R. S.} and Schaffer, {D. V.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1038/gt.2010.81",
language = "English",
volume = "17",
pages = "1384--1389",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "11",

}

Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery. / Jang, Jae-Hyung; Koerber, J. T.; Gujraty, K.; Bethi, S. R.; Kane, R. S.; Schaffer, D. V.

In: Gene Therapy, Vol. 17, No. 11, 01.11.2010, p. 1384-1389.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery

AU - Jang, Jae-Hyung

AU - Koerber, J. T.

AU - Gujraty, K.

AU - Bethi, S. R.

AU - Kane, R. S.

AU - Schaffer, D. V.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Adeno-associated viral (AAV) vectors, which are undergoing broad exploration in clinical trials, have significant promise for therapeutic gene delivery because of their safety and delivery efficiency. Gene delivery technologies capable of mediating localized gene expression may further enhance the potential of AAV in a variety of therapeutic applications by reducing spread outside a target region, which may thereby reduce off-target side effects. We have genetically engineered an AAV variant capable of binding to surfaces with high affinity through a hexa-histidine metal-binding interaction. This immobilized AAV vector system mediates high-efficiency delivery to cells that contact the surface and thus may have promise for localized gene delivery, which may aid numerous applications of AAV delivery to gene therapy.

AB - Adeno-associated viral (AAV) vectors, which are undergoing broad exploration in clinical trials, have significant promise for therapeutic gene delivery because of their safety and delivery efficiency. Gene delivery technologies capable of mediating localized gene expression may further enhance the potential of AAV in a variety of therapeutic applications by reducing spread outside a target region, which may thereby reduce off-target side effects. We have genetically engineered an AAV variant capable of binding to surfaces with high affinity through a hexa-histidine metal-binding interaction. This immobilized AAV vector system mediates high-efficiency delivery to cells that contact the surface and thus may have promise for localized gene delivery, which may aid numerous applications of AAV delivery to gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=78149465127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149465127&partnerID=8YFLogxK

U2 - 10.1038/gt.2010.81

DO - 10.1038/gt.2010.81

M3 - Article

VL - 17

SP - 1384

EP - 1389

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 11

ER -